The Enigma of Mammaglobin: Redefining the Biomarker Paradigm in Breast Carcinoma.
biomarker
breast carcinoma
cancer progression
diagnosis
mammaglobin
metastasis
peritumoral expression
treatment strategies
tumoral expression
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
29 Aug 2023
29 Aug 2023
Historique:
received:
10
08
2023
revised:
23
08
2023
accepted:
29
08
2023
medline:
11
9
2023
pubmed:
9
9
2023
entrez:
9
9
2023
Statut:
epublish
Résumé
The continuous evolution of cancer biology has led to the discovery of mammaglobin, a potential novel biomarker for breast carcinoma. This review aims to unravel the enigmatic aspects of mammaglobin and elucidate its potential role in redefining the paradigm of breast carcinoma biomarkers. We will thoroughly examine its expression in tumoral and peritumoral tissues and its circulating levels in the blood, thereby providing insights into its possible function in cancer progression and metastasis. Furthermore, the potential application of mammaglobin as a non-invasive diagnostic tool and a target for personalized treatment strategies will be discussed. Given the increasing incidence of breast carcinoma worldwide, the exploration of novel biomarkers such as mammaglobin is crucial in advancing our diagnostic capabilities and treatment modalities, ultimately contributing to improved patient outcomes.
Identifiants
pubmed: 37686210
pii: ijms241713407
doi: 10.3390/ijms241713407
pmc: PMC10487666
pii:
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Faculty of Medical Sciences, University of Kragujevac, Serbia
ID : JP17/19
Références
World J Clin Oncol. 2022 Jun 24;13(6):529-539
pubmed: 35949431
Cancers (Basel). 2021 Sep 03;13(17):
pubmed: 34503265
Breast Cancer Res Treat. 2008 Aug;110(3):453-63
pubmed: 17874294
Breast Cancer Res Treat. 2003 May;79(1):133-6
pubmed: 12779090
Eur J Surg Oncol. 2007 Feb;33(1):16-22
pubmed: 17071045
Drug Des Devel Ther. 2022 Jan 26;16:305-314
pubmed: 35115765
Gland Surg. 2022 Oct;11(10):1628-1638
pubmed: 36353583
Lancet Glob Health. 2018 Aug;6(8):e885-e893
pubmed: 30012269
Mol Carcinog. 2016 Jul;55(7):1150-62
pubmed: 26207726
Int J Gynecol Pathol. 2008 Jul;27(3):418-25
pubmed: 18580321
Adv Clin Chem. 2014;64:241-68
pubmed: 24938021
Int J Clin Exp Pathol. 2009;2(4):384-9
pubmed: 19158935
J Immunother Cancer. 2022 Dec;10(12):
pubmed: 36517082
J Pathol. 1999 Sep;189(1):28-33
pubmed: 10451484
Clin Chem. 2006 Mar;52(3):345-51
pubmed: 16410341
Front Oncol. 2022 Apr 28;12:866293
pubmed: 35574364
Int J Cancer. 2013 Jul;133(1):1-13
pubmed: 23280579
Hum Genomics. 2011 Oct;5(6):691-702
pubmed: 22155607
BMC Cancer. 2014 Jul 28;14:546
pubmed: 25070172
Breast Cancer Res Treat. 2012 Nov;136(2):331-45
pubmed: 23073759
Indian J Med Res. 2014 May;139(5):675-85
pubmed: 25027076
Clin Cancer Res. 2003 Feb;9(2):749-54
pubmed: 12576445
Eur J Breast Health. 2019 Jul 01;15(3):163-170
pubmed: 31312792
J Clin Oncol. 1999 Jul;17(7):2015-9
pubmed: 10561252
Int J Cancer. 2002 Dec 10;102(5):499-506
pubmed: 12432553
Sci Rep. 2019 Feb 19;9(1):2318
pubmed: 30783124
PLoS One. 2019 May 23;14(5):e0216989
pubmed: 31120936
Adv Exp Med Biol. 2017;1026:27-39
pubmed: 29282678
Onco Targets Ther. 2018 May 30;11:3245-3255
pubmed: 29881297
Cancers (Basel). 2020 Sep 27;12(10):
pubmed: 32992445
Semin Diagn Pathol. 2022 Sep;39(5):355-366
pubmed: 35803776
Breast Cancer (Dove Med Press). 2019 Mar 18;11:143-150
pubmed: 30936743
Clin Exp Metastasis. 2010 Apr;27(4):251-9
pubmed: 20364301
G Chir. 2014 Nov-Dec;35(11-12):260-5
pubmed: 25644726
Breast Cancer Res Treat. 2004 Nov;88(1):29-41
pubmed: 15538043
Acta Biochim Pol. 2004;51(3):747-55
pubmed: 15448736
Oncoimmunology. 2016 Feb 26;5(2):e1069940
pubmed: 27057470
Cancers (Basel). 2021 Apr 23;13(9):
pubmed: 33922795
EMBO Rep. 2014 Mar;15(3):244-53
pubmed: 24531722
Surgery. 2003 Jan;133(1):74-80
pubmed: 12563241
Biochemistry. 2002 May 28;41(21):6714-22
pubmed: 12022875
Int J Oncol. 2007 Apr;30(4):955-62
pubmed: 17332935
Clin Chem. 2002 Aug;48(8):1362-4
pubmed: 12142396
Breast Cancer Res. 2015 Jan 27;17:11
pubmed: 25848861
Immunotherapy. 2010 Mar;2(2):213-26
pubmed: 20635929
J Intern Med. 2013 Aug;274(2):113-26
pubmed: 23844915
Nat Rev Clin Oncol. 2019 May;16(5):296-311
pubmed: 30563978
Cancer Res. 1998 Oct 15;58(20):4581-4
pubmed: 9788605
Sci Rep. 2020 Aug 3;10(1):13061
pubmed: 32747636
Clin Biochem. 2004 Apr;37(4):249-57
pubmed: 15003725
Ann Surg. 2004 Jun;239(6):828-37; discussion 837-40
pubmed: 15166962
J BUON. 2016 Jan-Feb;21(1):35-41
pubmed: 27061528
FEBS Open Bio. 2022 Oct;12(10):1797-1813
pubmed: 35945910
Br J Radiol. 2022 Feb 1;95(1130):20211033
pubmed: 34905391
Cancer Res. 1996 Feb 15;56(4):860-5
pubmed: 8631025
Cancer Invest. 2014 Jan;32(1):22-9
pubmed: 24328556
Anticancer Res. 2006 Sep-Oct;26(5B):3855-60
pubmed: 17094413
Cancers (Basel). 2022 Aug 30;14(17):
pubmed: 36077752
PLoS One. 2021 Sep 23;16(9):e0255580
pubmed: 34555047
Mol Ther. 2004 Oct;10(4):758-67
pubmed: 15451460
Breast Cancer Res Treat. 2013 Feb;138(1):109-18
pubmed: 22678162
Clin Chem. 2002 Aug;48(8):1194-7
pubmed: 12142372
Ann N Y Acad Sci. 2000;923:78-89
pubmed: 11193781
J Cancer. 2014 Jan 05;5(1):58-68
pubmed: 24396498
Mol Biol Int. 2014;2014:852748
pubmed: 25276427
Med J Islam Repub Iran. 2016 May 15;30:369
pubmed: 27493913
Histopathology. 2016 Jan;68(1):152-67
pubmed: 26768036
Ann Oncol. 2001 Dec;12(12):1693-8
pubmed: 11843246
BMC Cancer. 2006 Apr 09;6:88
pubmed: 16603086
Signal Transduct Target Ther. 2020 Mar 12;5(1):28
pubmed: 32296047
Cancers (Basel). 2021 Aug 25;13(17):
pubmed: 34503097
Cancer. 2020 May 15;126 Suppl 10:2379-2393
pubmed: 32348566
Breast Cancer (Auckl). 2019 Jun 26;13:1178223419858957
pubmed: 31263371
Cancer Biol Ther. 2013 Apr;14(4):327-32
pubmed: 23358476
Biomolecules. 2022 Jul 23;12(8):
pubmed: 35892331
Biomark Med. 2011 Apr;5(2):249-60
pubmed: 21473729
Cancer Res. 2011 Feb 1;71(3):1050-9
pubmed: 21169406
J Cell Physiol. 2019 Dec;234(12):21425-21435
pubmed: 31042009
Br J Cancer. 2021 Jan;124(1):13-26
pubmed: 33239679
J Natl Cancer Inst. 2004 Sep 15;96(18):1388-96
pubmed: 15367572
Breast Cancer Res Treat. 2011 May;127(1):81-9
pubmed: 20544273
Geburtshilfe Frauenheilkd. 2013 Sep;73(9):932-940
pubmed: 24771945
Diagnostics (Basel). 2023 Mar 22;13(6):
pubmed: 36980510
Cancer. 2018 Sep 1;124(17):3500-3509
pubmed: 30189117
Biomed Pharmacother. 2022 Feb;146:112488
pubmed: 34894516
Ann N Y Acad Sci. 2000;923:348-54
pubmed: 11193777
Iran Biomed J. 2015;19(1):35-44
pubmed: 25605488
J Med Life. 2015;8(Spec Iss 4):6-11
pubmed: 28316699
Diagnostics (Basel). 2022 Dec 12;12(12):
pubmed: 36553136
Curr Cancer Drug Targets. 2004 Sep;4(6):531-42
pubmed: 15462037
J Thorac Dis. 2010 Jun;2(2):100-10
pubmed: 22263027
Ann Oncol. 2002 Mar;13(3):422-9
pubmed: 11996474
Nat Med. 2021 Jan;27(1):34-44
pubmed: 33442008
Signal Transduct Target Ther. 2021 Nov 22;6(1):404
pubmed: 34803167
Breast Cancer Res Treat. 2005 Jun;91(3):271-8
pubmed: 15952060
Cancer Cell Int. 2009 Mar 23;9:8
pubmed: 19309500
Clin Chem. 2004 Nov;50(11):2069-76
pubmed: 15375015